Disclosed are pyrimidine derivatives for use as a sphingosine 1-phosphate 1 (S1P1) receptor agonists, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions or diseases mediated by S1P1 receptors, particularly multiple sclerosis.
本文披露了用作神经酰胺1-
磷酸1(S1P1)受体激动剂的
嘧啶衍
生物,其制备方法,含有它们的药物组合物以及它们在治疗由S1P1受体介导的疾病或症状,尤其是多发性硬化症方面的用途。